Business Description
Shuttle Pharmaceuticals Holdings Inc. is a clinical-stage company focused on discovering and developing new treatments for cancer. Founded in 2012 and based in Gaithersburg, Maryland, the company has several drug candidates in development targeting brain tumors, sarcomas, and breast cancer. Its lead product, Ropidoxuridine, is taken by mouth and is currently being tested in patients, while additional compounds in earlier stages of research aim to work through the body's immune system and other biological pathways involved in cancer growth.
